Yavlovich Amichai, Smith Brandon, Gupta Kshitij, Blumenthal Robert, Puri Anu
Center for Cancer Research Nanobiology Program, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland 21702-1201, USA.
Mol Membr Biol. 2010 Oct;27(7):364-81. doi: 10.3109/09687688.2010.507788. Epub 2010 Oct 13.
Radiation-based therapies aided by nanoparticles have been developed for decades, and can be primarily categorized into two main platforms. First, delivery of payload of photo-reactive drugs (photosensitizers) using the conventional nanoparticles, and second, design and development of photo-triggerable nanoparticles (primarily liposomes) to attain light-assisted on-demand drug delivery. The main focus of this review is to provide an update of the history, current status and future applications of photo-triggerable lipid-based nanoparticles (light-sensitive liposomes). We will begin with a brief overview on the applications of liposomes for delivery of photosensitizers, including the choice of photosensitizers for photodynamic therapy, as well as the currently available light sources (lasers) used for these applications. The main segment of this review will encompass the details of strategies used to develop photo-triggerable liposomes for their drug delivery function. The principles underlying the assembly of photoreactive lipids into nanoparticles (liposomes) and photo-triggering mechanisms will be presented. We will also discuss factors that limit the applications of these liposomes for in vivo triggered drug delivery and emerging concepts that may lead to the biologically viable photo-activation strategies. We will conclude with our view point on the future perspectives of light-sensitive liposomes in the clinic.
基于纳米颗粒辅助的放射疗法已经发展了几十年,主要可分为两个主要平台。第一,使用传统纳米颗粒递送光反应性药物(光敏剂)的payload,第二,设计和开发光触发纳米颗粒(主要是脂质体)以实现光辅助按需给药。本综述的主要重点是提供光触发脂质基纳米颗粒(光敏脂质体)的历史、现状和未来应用的最新情况。我们将首先简要概述脂质体在递送光敏剂方面的应用,包括用于光动力疗法的光敏剂的选择,以及目前用于这些应用的光源(激光)。本综述的主要部分将涵盖用于开发具有药物递送功能的光触发脂质体的策略细节。将介绍光反应性脂质组装成纳米颗粒(脂质体)的原理和光触发机制。我们还将讨论限制这些脂质体在体内触发药物递送应用的因素以及可能导致具有生物学可行性的光激活策略的新兴概念。我们将以我们对光敏脂质体在临床上的未来前景的观点作为结论。